ProSomnus, Inc.
OSAPQ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$243.51K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $243,509.00 |
|---|---|
| Enterprise Value | $16.14 Million |
| Earnings per Share | $-1.49 |
| Beta | 0.17 |
| Outstanding Shares | 17,393,524 |
Return
| Return on Equity | 60.88% |
|---|---|
| Return on Assets | -113.05% |
| Return on Invested Capital | -222.07% |
Valuation & Multiples
| P/E Ratio | -0.32 |
|---|---|
| PEG | 0.02 |
| Price to Sales | 0.01 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 0.51 |
| Enterprise Value to EBIT | -1.14 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.27 |
| Debt to Equity | -0.42 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About ProSomnus, Inc.
136 employees
CEO: Leonard Liptak
ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to slee...